Howard Marks Bausch Health Companies Inc. Transaction History
Oaktree Capital Management LP
- $3.94 Billion
- Q3 2025
A detailed history of Howard Marks (Oaktree Capital Management LP) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Oaktree Capital Management LP holds 1,270,000 shares of BHC stock, worth $7.98 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
1,270,000
Previous 1,270,000
-0.0%
Holding current value
$7.98 Million
Previous $8.46 Million
3.16%
% of portfolio
0.21%
Previous 0.23%
Shares
2 transactions
Others Institutions Holding BHC
# of Institutions
262Shares Held
207MCall Options Held
2.54MPut Options Held
6.46M-
John Paulson Paulson & Co. Inc. | New York, Ny70.8MShares$444 Million16.32% of portfolio
-
Nomura Holdings Inc Tokyo, M015.7MShares$98.6 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$81.6 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$76.9 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A610.5MShares$66 Million0.01% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.27B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...